Leukemia Burden Impacts the Efficacy and Toxicity of Blinatumomab in Pediatric B‐Cell Acute Lymphoblastic Leukemia

ABSTRACT Background Blinatumomab has been approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). This study aimed to investigate the association between leukemia burden and the efficacy of blinatumomab in real‐world applications. Methods A real‐world study was conducted...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Weiling Yan, Shaoyan Hu, Wenjin Gao, Lihua Yang, Yan Gu, Yufeng Liu, Yunyan He, Dunhua Zhou, Wenting Hu, Xue Tang, Ming Sun, Lili Song, Wenyu Yang, Yalan You, Yongmin Tang, Xiaojun Xu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-08-01
coleção:	Cancer Medicine
Assuntos:	acute lymphoblastic leukemia blinatumomab pediatric real‐world study
Acesso em linha:	https://doi.org/10.1002/cam4.71159
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!